Related references
Note: Only part of the references are listed.Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
Sami Qadri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis
Mazen Noureddin et al.
JOURNAL OF HEPATOLOGY (2022)
New drugs for NASH
Somaya A. M. Albhaisi et al.
LIVER INTERNATIONAL (2021)
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
Philip N. Newsome et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease
Feng Gao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
Stephen A. Harrison et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
Beth A. Davison et al.
JOURNAL OF HEPATOLOGY (2020)
Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study
Debashis Haldar et al.
JOURNAL OF HEPATOLOGY (2019)
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
Jerome Boursier et al.
JOURNAL OF HEPATOLOGY (2019)
Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study
Ramy Younes et al.
LIVER INTERNATIONAL (2018)
Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH
J. Boursier et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation
David Goldberg et al.
GASTROENTEROLOGY (2017)
Prevalence of Chronic Liver Disease and Cirrhosis by Underlying Cause in Understudied Ethnic Groups: The Multiethnic Cohort
Veronica Wendy Setiawan et al.
HEPATOLOGY (2016)
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease
Konstantin Kazankov et al.
LIVER INTERNATIONAL (2016)
Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease
Pierre Bedossa
HEPATOLOGY (2014)
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson et al.
JOURNAL OF HEPATOLOGY (2014)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Share Paper
